ArticleNature medicine2026
Retraction Note: Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial.
Abstract readRetraction Notice
In one paragraph
Article in Nature medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cancer Chemoimmunotherapy: Time Will Tell.Cancer immunology research · 2026Article
Corrections and comments
- Retraction of
Authors and funding
28 authors.
Zhe Huang *Early Phase Clinical Trial Center, Department of Investigational Cancer Therapeutics, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Liang Zeng *Early Phase Clinical Trial Center, Department of Investigational Cancer Therapeutics, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Zhaohui Ruan *Early Phase Clinical Trial Center, Department of Investigational Cancer Therapeutics, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Qun Zeng *Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Huan YanEarly Phase Clinical Trial Center, Department of Investigational Cancer Therapeutics, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Wenjuan JiangDepartment of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Yi XiongDepartment of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Chunhua ZhouDepartment of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Haiyan YangDepartment of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Li LiuDepartment of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Jiacheng DaiEarly Phase Clinical Trial Center, Department of Investigational Cancer Therapeutics, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Nachuan ZouEarly Phase Clinical Trial Center, Department of Investigational Cancer Therapeutics, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Shidong XuEarly Phase Clinical Trial Center, Department of Investigational Cancer Therapeutics, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Ya WangDepartment of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Zhan WangDepartment of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Jun DengEarly Phase Clinical Trial Center, Department of Investigational Cancer Therapeutics, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Xue ChenEarly Phase Clinical Trial Center, Department of Investigational Cancer Therapeutics, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Jing WangEarly Phase Clinical Trial Center, Department of Investigational Cancer Therapeutics, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Hua XiangDepartment of Interventional Vascular Surgery, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Xiaomei LiResearch Unit 'Chronotherapy, Cancer, Transplantation', Faculty of Medicine, Paris-Saclay University, Hospital Paul Brousse, Villejuif, France.
Boris DuchemannResearch Unit 'Chronotherapy, Cancer, Transplantation', Faculty of Medicine, Paris-Saclay University, Hospital Paul Brousse, Villejuif, France.
Guoqiang ChenKey Laboratory of Tropical Translational Medicine of Ministry of Education, School of Basic Medicine, Hainan Academy of Medical Sciences, Hainan Medical University, Haikou, China.ORCID http://orcid.org/0000-0003-4936-2363
Yang XiaKey Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.ORCID http://orcid.org/0000-0003-2487-2244
Tony MokThe Chinese University of Hong Kong, Hong Kong, China. tony@clo.cuhk.edu.hk.ORCID http://orcid.org/0000-0002-8251-0551
Christoph ScheiermannDepartment of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland. christoph.scheiermann@unige.ch.ORCID http://orcid.org/0000-0002-9212-0995
Francis LéviResearch Unit 'Chronotherapy, Cancer, Transplantation', Faculty of Medicine, Paris-Saclay University, Hospital Paul Brousse, Villejuif, France. francis.levi@universite-paris-saclay.fr.ORCID http://orcid.org/0000-0003-1364-7463
Nong YangDepartment of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China. yangnong0217@163.com.ORCID http://orcid.org/0000-0003-0997-3645
Yongchang ZhangEarly Phase Clinical Trial Center, Department of Investigational Cancer Therapeutics, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China. zhangyongchang@csu.edu.cn.ORCID http://orcid.org/0000-0002-6829-7176
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
PMID
42343117What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.